Taken together, these and other studies suggest that an integrative approach that combines multiple transcriptomic and genomic datasets might be well poised to identify new therapeutic avenues in MPNSTs and other NF1-related nerve sheath tumors. The gene discussed is NF1; the disease is nerve sheath neoplasm.